134 related articles for article (PubMed ID: 10995066)
1. Protease inhibitors: Part 4. Synthesis of weakly basic thrombin inhibitors incorporating pyridinium-sulfanilylaminoguanidine moieties.
Supuran CT; Briganti F; Scozzafava A; Ilies MA
J Enzyme Inhib; 2000; 15(4):335-56. PubMed ID: 10995066
[TBL] [Abstract][Full Text] [Related]
2. Protease inhibitors - Part 3. Synthesis of non-basic thrombin inhibitors incorporating pyridinium-sulfanilylguanidine moieties at the P1 site.
Scozzafava A; Briganti F; Supuran CT
Eur J Med Chem; 1999 Nov; 34(11):939-952. PubMed ID: 10889318
[TBL] [Abstract][Full Text] [Related]
3. Protease inhibitors: synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at P1.
Supuran CT; Scozzafava A; Briganti F; Clare BW
J Med Chem; 2000 May; 43(9):1793-806. PubMed ID: 10794696
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitors. Part 2. Weakly basic thrombin inhibitors incorporating sulfonyl-aminoguanidine moieties as S1 anchoring groups: synthesis and structure-activity correlations.
Clare BW; Scozzafava A; Briganti F; Iorga B; Supuran CT
J Enzyme Inhib; 2000; 15(3):235-64. PubMed ID: 10811030
[TBL] [Abstract][Full Text] [Related]
5. Protease inhibitors, part 13: Specific, weakly basic thrombin inhibitors incorporating sulfonyl dicyandiamide moieties in their structure.
Clare BW; Scozzafava A; Supuran CT
J Enzyme Inhib; 2001 Jan; 16(1):1-13. PubMed ID: 11496831
[TBL] [Abstract][Full Text] [Related]
6. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
Karle M; Knecht W; Xue Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
[TBL] [Abstract][Full Text] [Related]
7. Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.
De Simone G; Menchise V; Omaggio S; Pedone C; Scozzafava A; Supuran CT
Biochemistry; 2003 Aug; 42(30):9013-21. PubMed ID: 12885234
[TBL] [Abstract][Full Text] [Related]
8. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
Ganesh V; Lee AY; Clardy J; Tulinsky A
Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
Wienand A; Ehrhardt C; Metternich R; Tapparelli C
Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydro-isoquinoline-based factor Xa inhibitors.
Kucznierz R; Grams F; Leinert H; Marzenell K; Engh RA; von der Saal W
J Med Chem; 1998 Dec; 41(25):4983-94. PubMed ID: 9836616
[TBL] [Abstract][Full Text] [Related]
12. Azetidin-2-one derivatives as inhibitors of thrombin.
Han WT; Trehan AK; Wright JJ; Federici ME; Seiler SM; Meanwell NA
Bioorg Med Chem; 1995 Aug; 3(8):1123-43. PubMed ID: 7582985
[TBL] [Abstract][Full Text] [Related]
13. Cyanopeptide analogues: new lead structures for the design and synthesis of new thrombin inhibitors.
Radau G; Stürzebecher J
Pharmazie; 2002 Nov; 57(11):729-32. PubMed ID: 12611274
[TBL] [Abstract][Full Text] [Related]
14. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
[TBL] [Abstract][Full Text] [Related]
15. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
[TBL] [Abstract][Full Text] [Related]
16. Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
Katz BA; Elrod K; Verner E; Mackman RL; Luong C; Shrader WD; Sendzik M; Spencer JR; Sprengeler PA; Kolesnikov A; Tai VW; Hui HC; Breitenbucher JG; Allen D; Janc JW
J Mol Biol; 2003 May; 329(1):93-120. PubMed ID: 12742021
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics.
Ogbu CO; Qabar MN; Boatman PD; Urban J; Meara JP; Ferguson MD; Tulinsky J; Lum C; Babu S; Blaskovich MA; Nakanishi H; Ruan F; Cao B; Minarik R; Little T; Nelson S; Nguyen M; Gall A; Kahn M
Bioorg Med Chem Lett; 1998 Sep; 8(17):2321-6. PubMed ID: 9873535
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
[TBL] [Abstract][Full Text] [Related]
19. Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets.
Katz BA; Sprengeler PA; Luong C; Verner E; Elrod K; Kirtley M; Janc J; Spencer JR; Breitenbucher JG; Hui H; McGee D; Allen D; Martelli A; Mackman RL
Chem Biol; 2001 Nov; 8(11):1107-21. PubMed ID: 11731301
[TBL] [Abstract][Full Text] [Related]
20. Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl group.
Costanzo MJ; Maryanoff BE; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Kauffman JA; Lewis JM; Krishnan R; Tulinsky A
J Med Chem; 1996 Aug; 39(16):3039-43. PubMed ID: 8759623
[No Abstract] [Full Text] [Related]
[Next] [New Search]